News & Updates

Wet cupping therapy may help relieve migraine headaches

18 Oct 2024

Cupping therapy, especially wet cupping, appears to yield high treatment success rates, helping reduce pain intensity without increasing the risk of adverse events (AEs) among individuals with migraine headaches, according to the results of a systematic review and meta-analysis.

Wet cupping therapy may help relieve migraine headaches

18 Oct 2024

Fuzuloparib ± apatinib improves PFS in BRCA-mutated metastatic breast cancer

18 Oct 2024 by

Treatment with fuzuloparib, with or without apatinib, significantly improved progression-free survival (PFS) in patients with HER2– metastatic breast cancer (mBC) harbouring germline BRCA1/2 (gBRCA1/2) mutations compared with standard chemotherapy, according to results of a phase III study presented at ESMO 2024.

Fuzuloparib ± apatinib improves PFS in BRCA-mutated metastatic breast cancer

18 Oct 2024

Voice-activated CBT for insomnia works for breast cancer survivors

17 Oct 2024

An in-home, voice-activated cognitive behavioural therapy for insomnia (CBT-I) program appears to help breast cancer survivors sleep, according to a study.

Voice-activated CBT for insomnia works for breast cancer survivors

17 Oct 2024

Group intervention may prevent maternal obesity transmission

17 Oct 2024

A group prenatal care intervention appears beneficial in addressing several factors associated with intergenerational transmission of obesity, suggests a study in American Samoa.

Group intervention may prevent maternal obesity transmission

17 Oct 2024

Antipsychotic resistance tied to poorer cognitive function in schizophrenia

17 Oct 2024 by

Resistance to antipsychotic treatment may result in worse cognitive function among patients with schizophrenia, with disorganization, doses, and negative symptoms playing a major role in this association, according to a Singapore study.

Antipsychotic resistance tied to poorer cognitive function in schizophrenia

17 Oct 2024

Triamcinolone acetonide injection helps prevent macular edema after cataract surgery

17 Oct 2024

Treatment with subconjunctival triamcinolone acetonide (TA) results in a reduced risk of postoperative macular edema (ME), particularly the 10-mg/ml high-dose (4 mg) group, reports a study. Additionally, the risk of glaucoma-related events is similar to that of topical groups.

Triamcinolone acetonide injection helps prevent macular edema after cataract surgery

17 Oct 2024

Topical delgocitinib holds whip hand over oral systemic Tx in head-to-head hand eczema trial

17 Oct 2024 by

In the phase III head-to-head DELTA FORCE trial, topical delgocitinib cream gains the upper hand over oral alitretinoin – the only oral systemic therapy approved for the treatment of severe chronic hand eczema (CHE) in adults with inadequate response to topical corticosteroids.

Topical delgocitinib holds whip hand over oral systemic Tx in head-to-head hand eczema trial

17 Oct 2024

Home-based as good as office-based phototherapy for psoriasis

17 Oct 2024

Phototherapy, whether performed at home or in the clinic office, helps improve outcomes in plaque or guttate psoriasis, with the home-based procedure being associated with less financial burden to patients, according to a study.

Home-based as good as office-based phototherapy for psoriasis

17 Oct 2024

44 years of UKPDS: Legacy effect of early, intensive glycaemic control still holds true

17 Oct 2024 by

Early and intensive glycaemic control continues to reduce risks of mortality, MI, and microvascular complications even at 44 years after the UKPDS study’s initiation, according to follow-up data presented at the EMW Symposium 2024.

44 years of UKPDS: Legacy effect of early, intensive glycaemic control still holds true

17 Oct 2024

Patients with scalp psoriasis experience first-hand improvements in itch, flaking, pain from deucravacitinib

17 Oct 2024 by

An interim analysis of PROs from the PSORIATYK SCALP trial shows that treatment with the allosteric TYK2 inhibitor deucravacitinib significantly reduces itch, flaking, and pain specific to the scalp, as well as whole-body itch, vs placebo at week 16 in patients with moderate-to-severe scalp psoriasis, including those with less extensive BSA involvement

Patients with scalp psoriasis experience first-hand improvements in itch, flaking, pain from deucravacitinib

17 Oct 2024

News & Updates

Filter by Specialty:

Specialty:

Wet cupping therapy may help relieve migraine headaches

Wet cupping therapy may help relieve migraine headaches

Fuzuloparib ± apatinib improves PFS in BRCA-mutated metastatic breast cancer

Fuzuloparib ± apatinib improves PFS in BRCA-mutated metastatic breast cancer

Voice-activated CBT for insomnia works for breast cancer survivors

Voice-activated CBT for insomnia works for breast cancer survivors

Group intervention may prevent maternal obesity transmission

Group intervention may prevent maternal obesity transmission

Antipsychotic resistance tied to poorer cognitive function in schizophrenia

Antipsychotic resistance tied to poorer cognitive function in schizophrenia

Triamcinolone acetonide injection helps prevent macular edema after cataract surgery

Triamcinolone acetonide injection helps prevent macular edema after cataract surgery

Topical delgocitinib holds whip hand over oral systemic Tx in head-to-head hand eczema trial

Topical delgocitinib holds whip hand over oral systemic Tx in head-to-head hand eczema trial

Home-based as good as office-based phototherapy for psoriasis

Home-based as good as office-based phototherapy for psoriasis

44 years of UKPDS: Legacy effect of early, intensive glycaemic control still holds true

44 years of UKPDS: Legacy effect of early, intensive glycaemic control still holds true

Patients with scalp psoriasis experience first-hand improvements in itch, flaking, pain from deucravacitinib

Patients with scalp psoriasis experience first-hand improvements in itch, flaking, pain from deucravacitinib